These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 9793791)
21. Preoperative intra-aortic balloon pump to reduce mortality in coronary artery bypass graft: a meta-analysis of randomized controlled trials. Zangrillo A; Pappalardo F; Dossi R; Di Prima AL; Sassone ME; Greco T; Monaco F; Musu M; Finco G; Landoni G Crit Care; 2015 Jan; 19(1):10. PubMed ID: 25588568 [TBL] [Abstract][Full Text] [Related]
22. [Do sport programmes lower mortality and morbidity in patients with coronary heart disease?]. Völker K Dtsch Med Wochenschr; 2012 Jan; 137(1-2):15. PubMed ID: 22234800 [No Abstract] [Full Text] [Related]
23. Handsearching the EMHJ for reports of randomized controlled trials by U.K. Cochrane Centre (Bahrain). Al Hajeri A; Al Sayyad J; Eisinga A East Mediterr Health J; 2006; 12 Suppl 2():S253-7. PubMed ID: 17361697 [TBL] [Abstract][Full Text] [Related]
24. A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years. Serruys PW; Farooq V; Vranckx P; Girasis C; Brugaletta S; Garcia-Garcia HM; Holmes DR; Kappetein AP; Mack MJ; Feldman T; Morice MC; Ståhle E; James S; Colombo A; Pereda P; Huang J; Morel MA; Van Es GA; Dawkins KD; Mohr FW; Steyerberg EW JACC Cardiovasc Interv; 2012 Jun; 5(6):606-17. PubMed ID: 22721655 [TBL] [Abstract][Full Text] [Related]
25. A commentary on Diabetic and non-diabetic patients with left main and/ or three-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents by Banning AP et al. Marx N Diab Vasc Dis Res; 2011 Apr; 8(2):173. PubMed ID: 21562069 [No Abstract] [Full Text] [Related]
26. Comparing outcomes of percutaneous transluminal coronary angioplasty with coronary artery bypass grafting; can routine health service data complement and enhance randomized controlled trials? Lewsey JD; Murray GD; Leyland AH; Boddy FA Eur Heart J; 1999 Dec; 20(23):1731-5. PubMed ID: 10562481 [TBL] [Abstract][Full Text] [Related]
27. Evidence based medicine. Adhikari N; Shrestha S; Ansari I Kathmandu Univ Med J (KUMJ); 2006; 4(3):383-9. PubMed ID: 18603939 [No Abstract] [Full Text] [Related]
28. Surgical versus percutaneous revascularization in patients with multivessel coronary artery disease. Davierwala PM; Mohr FW Curr Atheroscler Rep; 2014 Dec; 16(12):461. PubMed ID: 25344743 [TBL] [Abstract][Full Text] [Related]
29. Ischemic burden, treatment allocation, and outcomes in stable coronary artery disease. Farzaneh-Far A; Borges-Neto S Circ Cardiovasc Imaging; 2011 Nov; 4(6):746-53. PubMed ID: 22086945 [No Abstract] [Full Text] [Related]
30. Predicting long-term survival for coronary artery bypass graft surgery and percutaneous coronary intervention: another important step forward. Hannan EL Circulation; 2012 Mar; 125(12):1475-6. PubMed ID: 22361328 [No Abstract] [Full Text] [Related]
32. Use of coronary artery bypass surgical procedure and coronary angioplasty in treatment of coronary artery disease: changes during a 10-year period at Mayo Clinic Rochester. Harris WO; Mock MB; Orszulak TA; Schaff HV; Holmes DR Mayo Clin Proc; 1996 Oct; 71(10):927-35. PubMed ID: 8820766 [TBL] [Abstract][Full Text] [Related]
33. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Hueb W; Lopes N; Gersh BJ; Soares PR; Ribeiro EE; Pereira AC; Favarato D; Rocha AS; Hueb AC; Ramires JA Circulation; 2010 Sep; 122(10):949-57. PubMed ID: 20733102 [TBL] [Abstract][Full Text] [Related]
34. Perioperative outcomes in hybrid versus conventional surgical coronary artery revascularisation. Jones ML; Qiu S; Sudarshan C Interact Cardiovasc Thorac Surg; 2010 Sep; 11(3):292-6. PubMed ID: 20573651 [TBL] [Abstract][Full Text] [Related]
35. Multiarterial grafts improve the rate of early major adverse cardiac and cerebrovascular events in patients undergoing coronary revascularization: analysis of 12 615 patients with multivessel disease. Locker C; Schaff HV; Daly RC; Bell MR; Frye RL; Stulak JM; Said SM; Dearani JA; Joyce LD; Greason KL; Pochettino A; Li Z; Lennon RJ; Lerman A Eur J Cardiothorac Surg; 2017 Oct; 52(4):746-752. PubMed ID: 28595326 [TBL] [Abstract][Full Text] [Related]
36. Observational research in the evidence based environment: eclipsed by the randomised controlled trial? Stables RH Heart; 2002 Feb; 87(2):101-2. PubMed ID: 11796537 [No Abstract] [Full Text] [Related]
37. BARI 2D: headlines are not enough. King SB JACC Cardiovasc Interv; 2009 Aug; 2(8):809-10. PubMed ID: 19695556 [No Abstract] [Full Text] [Related]
38. The new 2011 ACCF/AHA Guidelines on Coronary Artery Bypass Grafting surgery: are they different from the 2010 ESC/EACTS Guidelines on Myocardial Revascularisation? Kolh P; Sousa Uva M; Wijns W EuroIntervention; 2012 May; 8(1):33-4. PubMed ID: 22580246 [No Abstract] [Full Text] [Related]
39. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience. Chieffo A; Magni V; Latib A; Maisano F; Ielasi A; Montorfano M; Carlino M; Godino C; Ferraro M; Calori G; Alfieri O; Colombo A JACC Cardiovasc Interv; 2010 Jun; 3(6):595-601. PubMed ID: 20630452 [TBL] [Abstract][Full Text] [Related]
40. A meta-analysis of ≥5-year mortality in randomized controlled trials of off-pump versus on-pump coronary artery bypass grafting. Takagi H; Hari Y; Mitta S; Kawai N; Ando T; J Card Surg; 2018 Nov; 33(11):716-724. PubMed ID: 30306622 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]